Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$164,374,971
-$24,601,593 QoQ
Shares Held
647,222
-16.3% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#232
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $812,352,405 across 9 Drug Manufacturers - General names. JNJ ranks #2 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
283,001 | $339,439,917 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
647,222 | $164,374,971 | |
| 3 | ABBV |
AbbVie Inc.
|
399,893 | $100,629,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
650,503 | $83,589,635 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
356,488 | $45,038,693 | |
| 6 | PFE |
Pfizer Inc
|
1,753,548 | $42,225,435 | |
| 7 | AMGN |
Amgen Inc
|
68,480 | $24,797,977 | |
| 8 | BIIB |
Biogen Inc.
|
34,879 | $7,535,956 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,374,971 | 647,222 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $188,976,564 | 773,100 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $134,672,712 | 650,750 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $118,419,595 | 638,656 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $87,183,895 | 570,762 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $94,603,096 | 570,448 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $81,674,723 | 564,754 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $91,056,003 | 561,866 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $90,567,897 | 619,649 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $100,146,608 | 633,078 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $100,734,917 | 642,688 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $100,697,203 | 646,531 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $115,361,481 | 696,964 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $107,926,035 | 696,297 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $132,671,922 | 751,044 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $136,863,334 | 837,802 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $148,642,791 | 837,377 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $139,387,495 | 786,478 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $114,652,653 | 670,209 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $118,069,420 | 731,080 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $112,375,249 | 682,137 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $93,233,289 | 567,285 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $87,385,874 | 555,254 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $85,159,508 | 572,001 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $85,312,064 | 606,642 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $83,172,349 | 634,274 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||